Correction: Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML.

Publication/Presentation Date

11-1-2021

Volume

56

Issue

11

First Page

2871

Last Page

2871

ISSN

1476-5365

Disciplines

Medicine and Health Sciences

PubMedID

34654887

Department(s)

Department of Medicine, Hematology-Medical Oncology Division

Document Type

Article

Share

COinS